Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication (Q39590608)

From Wikidata
Jump to navigation Jump to search
scientific article published on April 2011
edit
Language Label Description Also known as
English
Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication
scientific article published on April 2011

    Statements

    Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit